Chemoradiotherapy for high-risk stage II laryngeal cancer.

Satoshi HamauchiTomoya YokotaYusuke OnozawaHirofumi OgawaTsuyoshi OnoeTomoyuki KamijoYoshiyuki IidaTetsuro OnitsukaHirofumi Yasui

Published in: International journal of clinical oncology (2020)

CRT may provide better locoregional control than RT alone in high-risk stage II laryngeal cancer.